Charts Thiogenesis Therapeutics, Corp.

Stocks

Market Closed - Toronto S.E. 10:58:34 2026-08-24 EDT			5-day change	1st Jan Change
0.5100 ^CAD	0.00%		0.00%	-21.54%

08-06	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

Stock exchange

Toronto S.E. TTI 0.5100 $ 0.00% 6.88K $

Markets		Price	Change	Volumes
Toronto S.E.	TTI	0.5100CAD	0.00%	6.88K $
Deutsche Boerse AG	Q8M	0.3300EUR	+13.01%	6.1K €
OTC Markets	TTIPF	0.4199USD	-0.02%	83.98 $

ProRealTime Chart